Finzati - Logo
COO logo

The Cooper Companies, Inc.

COO • Medical - Instruments & Supplies
$69.59
▼ -1.05 (-1.49%)
Current price
EarningsLatest report: Jan 31, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$13.69B
Growth
3.1%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 9.2%Positive revenue growth · 8.4%Positive free cash flow · 2.17Consistent free cash flow · 5/5Manageable debt level · 0.34
Financial data as of: Jan 31, 2026, 12:00 AM UTCLast earnings update: Mar 5, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$69.59
Change-1.49%
Shares Out196.70M
Market Cap$13.69B
Enterprise Value$16.06B
52W Range58.89 - 89.83
Beta0.87
P/E34.10
P/S3.30
P/B1.64
P/FCF27.87
EV/Sales3.87

Investment DNA

How strong this company looks for long-term investors

67
out of 100
Business Quality
Margins, moat, returns
59/100
Financial Strength
Debt, cash, stability
83/100
Growth Potential
Revenue and expansion
53/100
Price Attractiveness
Cheap or expensive today
59/100
Why this score▼
Stable or improving margins · 9.2%Positive revenue growth · 8.4%Positive free cash flow · 2.17Consistent free cash flow · 5/5Manageable debt level · 0.34Healthy liquidity · 1.89

Analyst view

Analyst sentiment and price target

COO
Analyst sentiment
Based on 25 analyst votes · 2026-09-05
80/100
Bullish
Bullish
16
Hold
8
Bearish
1
Price Target
2026-06-05
Low
$61.00
Mean
$80.33
Median
$85.50
High
$98.00

Company Overview

IPO: 1/21/1983
Industry: Medical - Instruments & Supplies
P/B i: 1.64
Debt / Equity i: 0.34
Operating Margin: 16.69%
Net Margin: 9.16%
ROE i: -
ROIC: -

Financial Health

Score17 / 20
Debt / Equity: 0.34
Current Ratio: 1.89
Quick Ratio: 1.13
Status: Strong

Insider Transactions

Recent executive and insider activity

Rosebrough Walter M Jr
Transaction: 04/01/2026
SELL
Change
-832
Price
Not reported
Filing
04/21/2026
Type
SELL
Rosebrough Walter M Jr
Transaction: 04/01/2026
BUY
Change
+832
Price
Not reported
Filing
04/21/2026
Type
BUY
Rosebrough Walter M Jr
Transaction: 01/03/2026
BUY
Change
+832
Price
Not reported
Filing
04/21/2026
Type
BUY